Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.38
Delayed Data
As of Jul 26
 +0.02 / +1.47%
Today’s Change
1.13
Today|||52-Week Range
4.62
-50.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash65.2M35.8M185.7M21.6M
 
 
 
 
 
Short Term Investment Cash27.4M-29.4M149.9M-164.1M
 
 
 
 
 
Cash & Short Term Investments155.3M124.1M185.7M21.6M
 
 
 
 
 
 
ReceivablesReceivables5.9M3.3M6.5M17.5M
 
 
 
 
 
 
InventoriesInventories0.000.003.7M14.6M
 
 
 
 
Current AssetsOther Current Assets5.5M4.7M5.5M3.8M
 
 
 
 
 
Current Assets166.6M132.1M201.4M57.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross34.9M38.6M51.2M52.0M
 
 
 
 
 
Depreciation-21.5M-24.1M-29.3M-36.2M
 
 
 
 
 
Intangible Assets11.7M11.3M11.0M7.6M
 
 
 
 
 
Other Assets11.8M11.5M11.0M7.6M
 
 
 
 
 
Total Assets192.4M158.7M234.9M81.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M2.5M5.0M3.4M
 
 
 
 
 
Short Term Debt8.2M13.3M0.000.00
 
 
 
Accrued Expenses26.0M25.1M36.0M35.9M
 
 
 
 
 
Other Current Liabilities40.3M88.6M89.2M74.3M
 
 
 
 
 
Other Liabilities57.7M111.1M103.7M88.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt103.4M106.8M257.7M216.9M
 
 
 
 
 
Deferred Taxes-507.0K-496.0K-1.0M0.00
 
 
 
 
Other Liabilities1.2M1.2M4.9M3.4M
 
 
 
 
 
Total Liabilities235.5M260.7M418.6M334.1M
 
 
 
 
 
 
EquityMinority Interest-240.0K-268.0K-170.0K-1.8M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity-43.5M-102.1M-183.9M-251.1M
 
 
 
 
 
Total Shareholder Equity-43.5M-102.1M-183.9M-251.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding102.5M106.7M115.9M130.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.